• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中 Tau 磷酸化途径基因与脑脊液 Tau 水平。

Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.

机构信息

Geriatric Research, Education, and Clinical Center (GRECC), VA Puget Sound Health Care System, Seattle, Washington 98108, USA.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):874-83. doi: 10.1002/ajmg.b.32094. Epub 2012 Aug 27.

DOI:10.1002/ajmg.b.32094
PMID:22927204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3626266/
Abstract

Alzheimer's disease (AD) is characterized by the presence in the brain of amyloid plaques, consisting predominately of the amyloid β peptide (Aβ), and neurofibrillary tangles, consisting primarily of tau. Hyper-phosphorylated-tau (p-tau) contributes to neuronal damage, and both p-tau and total-tau (t-tau) levels are elevated in AD cerebrospinal fluid (CSF) compared to cognitively normal controls. Our hypothesis was that increased ratios of CSF phosphorylated-tau levels relative to total-tau levels correlate with regulatory region genetic variation of kinase or phosphatase genes biologically associated with the phosphorylation status of tau. Eighteen SNPs located within 5' and 3' regions of 5 kinase and 4 phosphatase genes, as well as two SNPs within regulatory regions of the MAPT gene were chosen for this analysis. The study sample consisted of 101 AD patients and 169 cognitively normal controls. Rs7768046 in the FYN kinase gene and rs913275 in the PPP2R4 phosphatase gene were both associated with CSF p-tau and t-tau levels in AD. These SNPs were also differentially associated with either CSF t-tau (rs7768046) or CSF p-tau (rs913275) relative to t-tau levels in AD compared to controls. These results suggest that rs7768046 and rs913275 both influence CSF tau levels in an AD-associated manner.

摘要

阿尔茨海默病(AD)的特征是大脑中存在淀粉样斑块,主要由淀粉样β肽(Aβ)组成,以及神经原纤维缠结,主要由tau 组成。过度磷酸化的 tau(p-tau)导致神经元损伤,与认知正常对照组相比,AD 脑脊液(CSF)中的 p-tau 和总 tau(t-tau)水平均升高。我们的假设是,CSF 中磷酸化 tau 水平与总 tau 水平的比值增加与激酶或磷酸酶基因的调节区域遗传变异相关,这些基因与 tau 的磷酸化状态有生物学关联。选择了位于 5 个激酶和 4 个磷酸酶基因的 5'和 3'区域内的 18 个单核苷酸多态性(SNP),以及 MAPT 基因调节区域内的两个 SNP 进行这项分析。研究样本包括 101 名 AD 患者和 169 名认知正常对照者。FYN 激酶基因中的 rs7768046 和 PPP2R4 磷酸酶基因中的 rs913275 均与 AD 患者的 CSF p-tau 和 t-tau 水平相关。这些 SNP 还与 AD 患者的 CSF t-tau(rs7768046)或 CSF p-tau(rs913275)与 t-tau 水平相关,与对照组相比存在差异。这些结果表明,rs7768046 和 rs913275 均以 AD 相关的方式影响 CSF tau 水平。

相似文献

1
Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.阿尔茨海默病中 Tau 磷酸化途径基因与脑脊液 Tau 水平。
Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):874-83. doi: 10.1002/ajmg.b.32094. Epub 2012 Aug 27.
2
Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.全基因组关联分析揭示了脑脊液中人类 Aβ42 和 τ 蛋白水平的遗传效应:一项病例对照研究。
BMC Neurol. 2010 Oct 8;10:90. doi: 10.1186/1471-2377-10-90.
3
Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.定量遗传学验证了先前的遗传变异,并确定了影响阿尔茨海默病脑脊液生物标志物的新的遗传参与者。
J Alzheimers Dis. 2018;66(2):639-652. doi: 10.3233/JAD-180512.
4
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.与脑脊液磷酸化 tau 水平相关的 SNPs 影响阿尔茨海默病的下降速度。
PLoS Genet. 2010 Sep 16;6(9):e1001101. doi: 10.1371/journal.pgen.1001101.
5
Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease.阿尔茨海默病患者脑脊液中双链 RNA 依赖性蛋白激酶水平升高。
Biol Psychiatry. 2012 May 1;71(9):829-35. doi: 10.1016/j.biopsych.2011.11.031. Epub 2012 Jan 26.
6
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.糖原合成酶激酶3β(GSK3B)的基因变异与阿尔茨海默病的生物标志物及认知功能相关。
J Alzheimers Dis. 2015;44(4):1313-22. doi: 10.3233/JAD-142025.
7
TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.TAU单倍型和赛托欣Q7R基因多态性不影响阿尔茨海默病患者的脑脊液 Tau水平,且与额颞叶痴呆或帕金森病无关。
Neurodegener Dis. 2005;2(1):28-35. doi: 10.1159/000086428.
8
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.IL1RAP 相关遗传变异与阿尔茨海默病相关 tau 蛋白在脑脊液中的浓度的关联。
Sci Rep. 2019 Feb 21;9(1):2460. doi: 10.1038/s41598-018-36650-3.
9
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.用于识别阿尔茨海默病淀粉样斑块病理的脑脊液β-淀粉样蛋白1-42、总tau蛋白和磷酸化tau181检测分析平台的比较。
Arch Neurol. 2011 Sep;68(9):1137-44. doi: 10.1001/archneurol.2011.105. Epub 2011 May 9.
10
Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.轻度阿尔茨海默病痴呆患者血清皮质醇水平与脑脊液中T-tau、P-tau 181和P-tau 231肽水平以及T-tau/Abeta 1-42比值呈负相关。
Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):80-5. doi: 10.1007/s00406-008-0838-3. Epub 2008 Sep 19.

引用本文的文献

1
FYN Tyrosine Kinase Gene Polymorphisms in Alcohol-Dependent Korean Patients.酒精依赖的韩国患者中FYN酪氨酸激酶基因多态性
Alpha Psychiatry. 2025 Feb 28;26(1):38752. doi: 10.31083/AP38752. eCollection 2025 Feb.
2
Fused multi-modal similarity network as prior in guiding brain imaging genetic association.融合多模态相似性网络作为指导脑成像基因关联的先验知识。
Front Big Data. 2023 May 5;6:1151893. doi: 10.3389/fdata.2023.1151893. eCollection 2023.
3
Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

本文引用的文献

1
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.tau 异常过度磷酸化:部位、调节及神经原纤维变性的分子机制。
J Alzheimers Dis. 2013;33 Suppl 1:S123-39. doi: 10.3233/JAD-2012-129031.
2
Fyn, a potential target for Alzheimer's disease.法因,阿尔茨海默病的一个潜在靶点。
J Alzheimers Dis. 2011;27(2):243-52. doi: 10.3233/JAD-2011-110353.
3
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
查尔酮及其类似物:阿尔茨海默病治疗和诊断应用。
Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.
4
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?Fyn 激酶在帕金森病和左旋多巴诱导运动障碍中的关键作用:一种新的治疗靶点?
Mol Neurobiol. 2021 Apr;58(4):1372-1391. doi: 10.1007/s12035-020-02201-z. Epub 2020 Nov 11.
5
Fyn Tyrosine Kinase as Harmonizing Factor in Neuronal Functions and Dysfunctions.Fyn 酪氨酸激酶作为神经元功能和失调的协调因子。
Int J Mol Sci. 2020 Jun 22;21(12):4444. doi: 10.3390/ijms21124444.
6
Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.调控区域基因变异与阿尔茨海默病中的FYN表达相关。
Neurobiol Aging. 2017 Mar;51:43-53. doi: 10.1016/j.neurobiolaging.2016.11.001. Epub 2016 Nov 15.
7
Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease.与阿尔茨海默病神经纤维缠结进展相关的基因。
Transl Psychiatry. 2014 Jun 10;4(6):e396. doi: 10.1038/tp.2014.35.
8
Genetic discoveries in AD using CSF amyloid and tau.利用脑脊液淀粉样蛋白和tau蛋白在阿尔茨海默病中的遗传学发现。
Curr Genet Med Rep. 2014 Mar 1;2(1):23-29. doi: 10.1007/s40142-014-0031-0.
9
Fyn kinase inhibition as a novel therapy for Alzheimer's disease.抑制Fyn激酶作为治疗阿尔茨海默病的新疗法。
Alzheimers Res Ther. 2014 Feb 5;6(1):8. doi: 10.1186/alzrt238. eCollection 2014.
10
Alzheimer's disease risk genes and the age-at-onset phenotype.阿尔茨海默病风险基因与发病年龄表型。
Neurobiol Aging. 2013 Nov;34(11):2696.e1-5. doi: 10.1016/j.neurobiolaging.2013.05.028. Epub 2013 Jul 17.
苏氨酸磷酸化的 tau 调节其与 Fyn SH2 结构域的相互作用,但不调节与 SH3 结构域的相互作用,改变 tau 的细胞定位。
FEBS J. 2011 Aug;278(16):2927-37. doi: 10.1111/j.1742-4658.2011.08218.x. Epub 2011 Jul 7.
4
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.tau 和 p-tau 作为脑脊液生物标志物在痴呆中的应用:一项荟萃分析。
Clin Chem Lab Med. 2011 Mar;49(3):353-66. doi: 10.1515/CCLM.2011.086. Epub 2011 Feb 23.
5
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.淀粉样蛋白-β/Fyn 诱导的突触、网络和认知障碍依赖于阿尔茨海默病多种小鼠模型中的 tau 水平。
J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011.
6
Post-translational modifications of tau protein: implications for Alzheimer's disease.tau 蛋白的翻译后修饰:对阿尔茨海默病的影响。
Neurochem Int. 2011 Mar;58(4):458-71. doi: 10.1016/j.neuint.2010.12.023. Epub 2011 Jan 6.
7
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.β淀粉样蛋白和 tau--阿尔茨海默病中的毒性双人舞。
Nat Rev Neurosci. 2011 Feb;12(2):65-72. doi: 10.1038/nrn2967. Epub 2010 Dec 31.
8
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.与脑脊液磷酸化 tau 水平相关的 SNPs 影响阿尔茨海默病的下降速度。
PLoS Genet. 2010 Sep 16;6(9):e1001101. doi: 10.1371/journal.pgen.1001101.
9
PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.PP2A 通过直接调节 tau 磷酸化和间接激活 GSK-3β来调节 tau 磷酸化。
J Alzheimers Dis. 2010;19(4):1221-9. doi: 10.3233/JAD-2010-1317.
10
ENCODE whole-genome data in the UCSC Genome Browser.在 UCSC 基因组浏览器中对全基因组数据进行编码。
Nucleic Acids Res. 2010 Jan;38(Database issue):D620-5. doi: 10.1093/nar/gkp961. Epub 2009 Nov 17.